News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,307 Results
Type
Article (87515)
Company Profile (807)
Press Release (773963)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233090)
Career Advice (4140)
Deals (39807)
Drug Delivery (139)
Drug Development (91275)
Employer Resources (203)
FDA (18294)
Job Trends (17406)
News (397471)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (128)
Alliances (56980)
ALS (147)
Alzheimer's disease (1689)
Antibody-drug conjugate (ADC) (262)
Approvals (18329)
Artificial intelligence (509)
Autoimmune disease (98)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (520)
Cancer (4113)
Cardiovascular disease (357)
Career advice (3562)
Career pathing (38)
CAR-T (252)
CDC (57)
Cell therapy (703)
Cervical cancer (33)
Clinical research (75738)
Collaboration (1436)
Company closure (4)
Compensation (949)
Complete response letters (62)
COVID-19 (2962)
CRISPR (84)
C-suite (613)
Cystic fibrosis (140)
Data (4794)
Decentralized trials (2)
Denatured (64)
Depression (113)
Diabetes (461)
Diagnostics (7102)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (242)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (99094)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133311)
Executive appointments (998)
FDA (20861)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1295)
Gene editing (178)
Generative AI (52)
Gene therapy (561)
GLP-1 (1033)
Government (5391)
Grass and pollen (8)
Guidances (372)
Healthcare (20938)
HIV (49)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (254)
Immuno-oncology (22)
Indications (58)
Infectious disease (3212)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (197)
Interviews (816)
IPO (17931)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (37)
Legal (10149)
Liver cancer (92)
Longevity (13)
Lung cancer (591)
Lymphoma (271)
Machine learning (32)
Management (66)
Manufacturing (666)
MASH (145)
Medical device (14904)
Medtech (14930)
Mergers & acquisitions (22777)
Metabolic disorders (1180)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (235)
Neuropsychiatric disorders (63)
Neuroscience (2752)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (60)
Obesity (569)
Opinion (315)
Ovarian cancer (140)
Pain (172)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (31)
Patents (428)
Patient recruitment (334)
Peanut (57)
People (66336)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23358)
Phase II (32860)
Phase III (24789)
Pipeline (2819)
Policy (301)
Postmarket research (3554)
Preclinical (10541)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (698)
Real estate (7422)
Recruiting (79)
Regulatory (28112)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (160)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (111)
Vaccines (1060)
Venture capital (67)
Weight loss (403)
Women's health (60)
Worklife (21)
Date
Today (47)
Last 7 days (711)
Last 30 days (2798)
Last 365 days (33418)
2025 (27843)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1282)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51058)
Australia (8976)
California (9751)
Canada (2918)
China (941)
Colorado (411)
Connecticut (432)
Delaware (279)
Europe (117318)
Florida (1437)
Georgia (322)
Hawaii (3)
Idaho (67)
Illinois (826)
India (55)
Indiana (481)
Iowa (20)
Japan (336)
Kansas (127)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1307)
Massachusetts (7294)
Michigan (318)
Minnesota (578)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2709)
New Mexico (32)
New York (2639)
North Carolina (1430)
North Dakota (10)
Northern California (4462)
Ohio (308)
Oklahoma (22)
Oregon (51)
Pennsylvania (2022)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (51)
South Dakota (1)
Southern California (3720)
Tennessee (152)
Texas (1534)
United States (35917)
Utah (294)
Virginia (253)
Washington D.C. (84)
Washington State (836)
West Virginia (4)
Wisconsin (100)
Wyoming (2)
There are 862,307 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Pfizer, As Promised, Sues To Stop Novo’s Rival Metsera Bid
Pfizer insists that Novo Nordisk’s unsolicited offer to acquire Metsera is an effort from the Danish pharma to “suppress competition.”
November 3, 2025
·
2 min read
·
Tristan Manalac
Gene editing
FDA Eyes Accelerated Reviews for Gene Editing Therapies
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to outline his office’s thinking of accelerating gene editing reviews.
November 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Actimed Therapeutics Further Expands Intellectual Property Portfolio for Lead Compound with New Composition of Matter Patent in Japan
November 3, 2025
·
4 min read
Press Releases
Vicore Announces The Nomination Committee For The 2026 Annual General Meeting
November 3, 2025
·
2 min read
Press Releases
Ascelia Pharma Announces Management Changes to Support Future Growth
November 3, 2025
·
1 min read
Press Releases
Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes
November 3, 2025
·
19 min read
Press Releases
KCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle
November 3, 2025
·
3 min read
Press Releases
Kyowa Kirin International Announces Appointment of Julie Dehaene-Puype as President for the Region
November 3, 2025
·
3 min read
Press Releases
Merz Aesthetics® Introduces New BELOTERO® Syringe Offering Greater Precision, Comfort and Ease of Use
November 3, 2025
·
5 min read
Press Releases
Positive Phase III Data for Genentech’s Gazyva Show Significant Reduction in Disease Activity for Systemic Lupus Erythematosus
November 3, 2025
·
14 min read
1 of 86,231
Next
